Abstract: We examined the effects of L-ascorbic acid and its analogues on DNA synthesis and cell proliferation. We also investigated the signal transduction pathways involved in the induction of mitogenesis by L-ascorbic acid and its analogues using primary cultures of adult rat hepatocytes. Following a 4-h serum-free cultivation, both L-ascorbic acid 
Introduction
Mature rat liver in its normal state is quiescent. However, after extensive hepatic resection, the remaining hepatocytes proliferate to restore the original mass within 2 weeks (Michalopoulos and DeFrances, 1997; Fasto, 2000) . This regenerative process is regulated by multiple factors such as peptide growth factors, cytokines, and intermediary metabolites. For example, epidermal growth factor (EGF), hepatocyte growth factor (HGF), insulin-like growth factor (IGF), and transforming growth factor (TGF)- all stimulate DNA synthesis in hepatocytes in vivo and in vitro (Borowiak et al., 2004; Fasto et al., 2006) . In the past decade, the cellular and molecular mechanisms of action of these multiple factors have been investigated in vitro using primary culture systems (Kimura and Ogihara, 1997a ,b, 1998 , 2005 Kimura et al., 2009) . In contrast, the role of vitamins in regulating hepatocyte mitogenesis remains to be elucidated. essential nutrient for the biosynthesis of collagen and L-carnitine, and for the conversion of dopamine to norepinephrine (Tajima and Pinnel, 1982; Li and Schellhorn, 2007) . The liver is an important target for the antioxidant effects of vitamin C, and plays a role in body vitamin homeostasis. Several reviews have summarized our current understanding of the physiology and pharmacology of vitamin C (Arrigoni and Tullio, 2002; Konya and Ferdinandy, 2006; Mandl et al., 2009 ).
L-ascorbic acid and its derivatives can inhibit or stimulate the growth of normal and tumor cells, depending on the cell type (Alcain and Burton, 1994; Belin et al., 2009; Koh et al., 1998; Pelin et al., 2009; Yang et al., 2006; Shibayama et al., 2008) . However, the cellular mechanisms of this inhibition or stimulation are poorly understood. Using primary cultures of adult rat hepatocytes, our aim was to test whether or not L-ascorbic acid and its analogues can stimulate hepatocyte DNA synthesis and cell proliferation, and if so, to analyze the signal transduction pathways involved.
Materials and Methods

Animals
Male Wistar rats (weight 200 -220 g) were obtained from Saitama Experimental Animal Co. (Saitama, Japan). They were maintained in an alternating 12-h light/dark cycle, with food and water available ad libitum.
The experimental protocol and handling of the animals during experiments were approved by the Experimental Animal Research Committee at the Josai University of Pharmaceutical Science, Japan.
Hepatocyte isolation and culture
The methods of hepatocyte isolation and culture have been described elsewhere (Nakamura et al., 1983) . In brief, the rats were anesthetized with an intraperitoneal injection of sodium pentobarbital (45 mg/kg). Two-step in situ collagenase perfusion was performed to facilitate disaggregation of the adult rat liver, as described previously (Seglen, 1975) .
The viability of hepatocytes consistently exceeded 96%, as determined by the trypan blue exclusion assay. Unless otherwise indicated, isolated hepatocytes were plated onto 6-well collagen-coated plastic culture dishes (35 mm diameter; Iwaki Glass Co., Tokyo, Japan) at a density of 3.3  10 4 cells/cm 2 in minimum essential medium containing 5% bovine calf serum and 10 -10 M dexamethasone for 3 h in 5% CO2 in air (Kimura et al., 2011) .
The medium was then changed, and the cells were cultured in serum-free minimum essential medium containing various concentrations of L-ascorbic acid or its analogues with or without specific inhibitors of signal transducers. In some experiments, the hepatocytes were cultured in serum-free minimum essential medium containing various concentrations of L-ascorbic acid or its analogues with or without monoclonal antibodies against several growth factor receptors and growth factors. In this study, minimum essential medium was used in place of Williams' medium E because it does not contain L-ascorbic acid, vitamin E, or vitamin K.
L-ascorbic acid, dehydroascorbic acid, isoascorbic acid and L-ascorbic acid 2-glucoside were buffered at pH 7.0 with sodium hydroxide and prepared fresh before each experiment.
Measurement of DNA synthesis
Hepatocyte DNA synthesis was assessed by measuring [ 3 H]-thymidine incorporation into acid-precipitable materials (Morley and Kingdon, 1972) .
After an initial attachment period of 3 h, the hepatocytes were washed twice with serum-free minimum essential medium and cultured in medium containing L-ascorbic acid or its analogues for a further 4 h or 21 h. The cells were pulse-stimulated for 2 h with [ 3 H]-thymidine (1.0 Ci/well) at 2 h and 19 h following the addition of L-ascorbic acid or its analogues.
Incorporation of [ 3 H]-thymidine into DNA was determined as described previously (Kimura and Ogihara, 1997a) . The hepatocyte protein content was determined using a modified Lowry procedure (Lee and Paxman, 1972) using bovine serum albumin as the standard. Data are expressed as dpm/h/mg cellular protein.
Counting the number of nuclei
The number of nuclei rather than the number of cells was counted, as previously described but with minor modifications (Nakamura et al., 1983) .
Briefly, the primary cultured hepatocytes were washed twice with 2 ml of Dulbecco's phosphate-buffered saline (pH 7.4). Then, the cells were lysed by incubation in 0.25 ml of 0.1 M citric acid containing 0.1 % Triton X-100 for 30 min at 37C. An equal volume of the nucleus suspension was mixed with 0.3% trypan blue in Dulbecco's phosphate-buffered saline (pH 7.4), and the nuclei were counted in a hemocytometer.
Determination of IGF-I receptor tyrosine kinase activity
Tyrosine phosphorylation of the IGF-I receptor was identified by Western blotting using anti-phosphotyrosine antibody (Li et al., 1994) . The phospho-IGF-I receptor antibody detects IGF-I receptor only when tyrosine 1161 in the carboxyl-terminal region is phosphorylated. This antibody does not cross-react with other tyrosine phosphorylated proteins. In brief, hepatocytes were freshly isolated and seeded at a density of 3.3  10 4 cells/cm 2 and cultured in minimal essential medium containing 5% newborn bovine serum. The medium was then aspirated and replaced, and the cells were further cultured in serum-free minimal essential medium with or without L-ascorbic acid or L-ascorbic acid 2-glucoside for various lengths of time. Cultured hepatocytes were washed once with ice-cold phosphate-buffered saline (pH 7.4) and then 0.2 ml of lysis buffer (20 mM Tris buffer, pH 7.5, 1% Triton X-100, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 1 mM -glycerophosphate, 1 mM phenylmethylsulfonyl fluoride) was added. Cell lysates were obtained by scraping the cells in lysis buffer, followed by sonication for 3 min. Cell lysates were centrifuged (3000  g for 3 min at 4C) to remove cellular debris, then denatured in boiling water for 5 min.
For immunoblotting analysis, samples of the supernatant (30 g/lane) were resolved by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) using a 7.5% polyacrylamide resolving gel, transferred to a polyvinylidene difluoride (PVDF) membrane, and immunoblotted with anti-phosphotyrosine antibody (Li et al., 1994) . Blots were developed by enhanced chemiluminescence following incubation with horseradish peroxidase (HRP)-conjugated secondary antibodies. The tyrosine kinase activity (autophosphorylation) of the phosphorylated p95-kDa protein (P-p95-kDa) was normalized to that of the total p95-kDa protein.
Determination of MAP kinase activity
Phosphorylated MAP kinase isoforms (P-p42 and P-p44 MAPK) were identified by Western blot analysis using a 1:1000 dilution of rabbit polyclonal dual phospho-specific antibodies (1 mg/ml) with HRP-conjugated goat anti-rabbit immunoglobulin G (IgG) as a secondary antibody, as previously described (Towbin et al., 1979; Okamoto et al., 2009 ).
Phosphorylated MAP kinase activity was normalized to the total MAP kinase activity. The data were calculated in arbitrary units and are expressed as means ± standard error of the means (S.E.M.). Statistical significance was set at *P < 0.05 compared with medium alone. The autodiagram is a representation of three experiments using different cell preparations.
Neutralization of growth factor receptors and growth factors
In experiments employing neutralizing antibodies, serum-free primary cultured hepatocytes were treated with maximum concentrations of monoclonal antibodies against HGF receptor, EGF receptor, insulin receptor, IGF-I receptor, IGF-II receptor, and tumor necrosis factor (TNF)- receptor-1 in the presence of L-ascorbic acid or L-ascorbic acid 2-glucoside.
In some experiments, serum-free primary cultured hepatocytes were treated with various concentrations of monoclonal antibodies against IGF-I receptors, IGF-I, and TGF- in the presence of L-ascorbic acid or L-ascorbic acid 2-glucoside.
Assay of [ 125 I]-IGF-I binding
Hepatocytes were isolated and cultured as described in Section 2.2. After 3h of culture, hepatocytes were washed 3 times with Hanks-10mM Hepes buffer (pH 7.4) supplemented with 8 mM glucose and 10 mg/mL bovine serum albumin. [ 125 I]-IGF-I binding to primary cultures of hepatocytes was measured according to the method as described elsewhere (Caro et al., 1988) . Briefly, the hepatocytes were incubated at 20C for 2h with conditions were the same as described in Section 2.8.
Materials
The following reagents were obtained from Sigma-Aldrich (St. Louis, MO, -10 -5 M), a stereoisomer of L-ascorbic acid, had no effect. Other lipidsoluble vitamins such as (+)--tocopherol (vitamin E; 10 -9 -10 -5 M) and phylloquinone (vitamin K1; 10 -9 -10 -5 M) also had no significant effect (data not shown).
Effects of specific inhibitors of growth-related signal transducers on
hepatocyte DNA synthesis and cell proliferation induced by L-ascorbic acid and L-ascorbic acid 2-glucoside We investigated whether or not the mitogenic responses of hepatocytes to L-ascorbic acid and L-ascorbic acid 2-glucoside were mediated by signal transducers, such as receptor tyrosine kinase, phosphatidylinositol 3-kinase (PI(3)K), mitogen-activated protein (MAP) kinase, and ribosomal protein p70 S6 kinase, by using the corresponding specific inhibitors of the signal transducers. The inhibitors used were AG1478 (3  10 -6 M), a specific inhibitor of receptor tyrosine kinase (Levizki and Gazit, 1995) , LY294002
(10 -7 M), a specific inhibitor of PI (3) or L-ascorbic acid 2-glucoside (10 -6 M) were radically inhibited by monoclonal anti-IGF-I receptor antibody (100 ng/ml). In contrast, L-ascorbic acid-and L-ascorbic acid 2-glucoside-induced hepatocyte DNA synthesis and cell proliferation were not significantly inhibited by monoclonal antibodies against IGF-II receptor (100 ng/ml), insulin receptor (100 ng/ml), EGF receptor (100 ng/ml), HGF receptor (100 ng/ml), or TNF- receptor-1 (100 ng/ml). These results indicate that anti-IGF-I receptor antibody specifically inhibits the effects of L-ascorbic acid (3  10 -6 M) and L-ascorbic acid 2-glucoside (10 -6 M) on hepatocyte mitogenesis. (Fig. 6B) , whereas rapamycin had no effect (Fig. 6B) . To exclude the possibility that L-ascorbic acid and L-ascorbic acid 2-glucoside selectively stimulate the secretion of a primary mitogen in an autocrine manner, thus inducing hepatocyte mitogenesis, we examined the effects of neutralizing antibodies against autocrine factors. Mitogens that could fulfill this requirement are TGF- and IGF-I, since hepatocytes express mRNA for TGF- and IGF-I, and cells can synthesize and store these primary mitogens (Michalopoulos and DeFrances, 1997) . Both TGF- and IGF-I are highly active growth factors for stimulating hepatocyte DNA synthesis and cell proliferation (Andus et al., 1991; Diehl and Rai, 1996; Fausto, 2000; Kimura and Ogihara, 1998; Kimura and Ogihara, 1999) . As shown in Figures 5A and 5B, the addition of neutralizing monoclonal antibodies against IGF-I and TGF- to the culture medium did not affect Thus, binding of an IGF to its receptor triggers a cascade of events that includes receptor autophosphorylation, phosphorylation of intracellular substrates, and activation of signaling pathways involved in growth regulation and metabolic processes (Czech, 1989; Davis, 1993; Humbel, 1990; Lund et al., 1986; Myers et al., 1993; Parrizas et al., 1997) . IGF-I receptor-mediated signal transduction pathways in normal and cancer cells have been studied in detail (Blume-Jensen and Hunter, 2001; Kurmasheva and Houghton, 2006; Melmed et al., 1996; Zha et al., 2010) .
To further confirm that L-ascorbic acid and L-ascorbic acid 2-glucoside induce hepatocyte DNA synthesis and cell proliferation through the IGF-I receptor-mediated signal transduction pathway, we investigated whether or not these agents actually stimulate IGF-I receptor tyrosine kinase and MAP kinase activities. Western blot analysis showed that L-ascorbic acid and L-ascorbic acid 2-glucoside can stimulate both hepatic IGF-I receptor tyrosine kinase and MAP kinase activities (Fig. 6) . These effects were blocked by specific inhibitors of receptor tyrosine kinase, which suggests that both L-ascorbic acid and L-ascorbic acid 2-glucoside act as IGF-I receptor agonists to induce hepatocyte mitogenesis (Fig. 6A ). In addition, AG1478, AG538, and LY294002 inhibited L-ascorbic acid-and L-ascorbic acid 2-glucoside-induced increases in the phosphorylation of p42 MAP kinase (Fig. 6B) , whereas rapamycin had no effect (Fig. 6B) . (Fig. 7A, B) and L-ascorbic acid-and L-ascorbic acid 2-glucoside-induced DNA synthesis and cell proliferation in primary cultures of adult rat hepatocytes ( Fig. 2A, B ) Taken together, a novel signal transduction pathway can rationally account for the hepatocyte DNA synthesis and cell proliferation induced by L-ascorbic acid and L-ascorbic acid 2-glucoside (Fig. 8 ).
In conclusion, the present results demonstrate for the first time that Hepatocyte DNA synthesis (A) and cell proliferation (B) were determined as described in Section 2. Data are expressed as mean  S.E.M. of three separate experiments. *P < 0.05, **P < 0.01 compared with the respective control. Fig. 4 Effect of anti-growth factor receptor monoclonal antibodies on L-ascorbic acid-and L-ascorbic acid 2-glucoside-induced hepatocyte DNA synthesis and cell proliferation. Hepatocytes at a cell density of 3.3  10 4 cells/cm 2 were plated and cultured for 3 h as described in the legend to Fig.   1 . After the 3-h attachment period (time zero), the medium was rapidly replaced with serum-free minimum essential medium and the hepatocytes were cultured with submaximal concentrations of monoclonal antibodies against hepatocyte growth factor (HGF) receptor (100 ng/ml), epidermal growth factor (EGF) receptor (100 ng/ml), insulin receptor (100 ng/ml), insulin-like growth factor (IGF)-I receptor (100 ng/ml), IGF-II receptor (100 ng/ml) or tumor necrosis factor (TNF)- receptor-1(100 ng/ml) in the presence of L-ascorbic acid (3  10 -6 M) or L-ascorbic acid 2-glucoside (10 -6 M) for an additional 4 h. Hepatocyte DNA synthesis (A) and cell proliferation (B) were determined as described in Section 2. Data are expressed as mean  S.E.M. of three separate experiments. **P < 0.01 compared with the respective control. 
